25 related articles for article (PubMed ID: 38554381)
21. Furanocoumarin compounds isolated from
Pengnam S; Jitkaroon W; Srisuphan R; Wongprayoon P; Rayanil KO; Charoensuksai P
Acta Pharm; 2024 Mar; 74(1):67-79. PubMed ID: 38554381
[TBL] [Abstract][Full Text] [Related]
22. Furanocoumarins in anticancer therapy - For and against.
Sumorek-Wiadro J; Zając A; Maciejczyk A; Jakubowicz-Gil J
Fitoterapia; 2020 Apr; 142():104492. PubMed ID: 32032635
[TBL] [Abstract][Full Text] [Related]
23. Anticancer Potential of Furanocoumarins: Mechanistic and Therapeutic Aspects.
Ahmed S; Khan H; Aschner M; Mirzae H; Küpeli Akkol E; Capasso R
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781533
[TBL] [Abstract][Full Text] [Related]
24. Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer.
Wulaningsih W; Wardhana A; Watkins J; Yoshuantari N; Repana D; Van Hemelrijck M
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008593. PubMed ID: 26869023
[TBL] [Abstract][Full Text] [Related]
25. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
Grivicich I; Mans DR; Peters GJ; Schwartsmann G
Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
